Regular ArticleSuppression of tumourigenicity, and induction of differentiation of the canine mammary tumour cell line MCM -B2 by Sodium phenylacetate (cas 114-70-5)

Add time:08/27/2019    Source:sciencedirect.com

The authors evaluated the cell growth inhibition, reduction of tumourigenicity, and differentiation-inducing effects of sodium phenylacetate (NaPA) on a canine mammary tumour cell line. Treatment of the canine mammary tumour cell line (MCM-B2) with NaPA lead to the arrest of cell growth. Sodium phenylacetate induced changes in the cells to non-malignant characteristics, as indicated by a reduction of colony formation in semi-solid agar and a decrease in tumour formation in athymic mice. Moreover, NaPA induced morphological changes from a spindle-shaped to an epithelial-like appearance, and significant accumulation of lipid droplets in the cytoplasm. Immunohistochemically, these treated cells reacted clearly with the antibody for keratin/cytokeratin. Sodium phenylacetate treatment increased the expression of the milk-specific genes α-lactalbumin and β-casein. The results of this study warrant an evaluation of NaPA in a clinical trial to establish its possible value as adjunctive treatment of malignant canine mammary tumours.

We also recommend Trading Suppliers and Manufacturers of Sodium phenylacetate (cas 114-70-5). Pls Click Website Link as below: cas 114-70-5 suppliers

Prev:In vitro differentiation of human neuroblastoma cells induced by Sodium phenylacetate (cas 114-70-5)
Next:Conformational analysis and electronic interactions of some 2-ethylsulfinyl-(4′-substituted)-phenylacetates)